Home/Filings/4/0001019687-15-001886
4//SEC Filing

PEREGRINE PHARMACEUTICALS INC 4

Accession 0001019687-15-001886

CIK 0000704562operating

Filed

May 11, 8:00 PM ET

Accepted

May 12, 8:05 PM ET

Size

5.4 KB

Accession

0001019687-15-001886

Insider Transaction Report

Form 4
Period: 2015-05-11
LYTLE PAUL J
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2015-05-11+150,0001,297,500 total
    Exercise: $1.31From: 2015-08-11Exp: 2025-05-11Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]This option vests in eight (8) equal quarterly installments over a two (2) year period beginning August 11, 2015 and each quarter thereafter until fully-vested.

Issuer

PEREGRINE PHARMACEUTICALS INC

CIK 0000704562

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000704562

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:05 PM ET
Size
5.4 KB